INSTRUCTIONS FOR USE Take one capsule with a glass of water/juice to aid swallowing
(Source: Drug Discovery Trends, 2025) Tirzepatide Expanding Globally Japan Launch March 2026 On March 19, 2026, Eli Lilly and Mitsubishi Tanabe Pharma announced the availability of Zepbound in Japan a market with approximately 28 million people living with obesity
However, their active ingredient, tirzepatide, may be compounded (custom-made) by a licensed pharmacist
Research also shows that tirzepatide tends to produce better blood sugar control than semaglutide
Its mechanism involves simultaneous modulation of multiple neurotrophic pathways: BDNF-like Activity: Components mimic brain-derived neurotrophic factor signaling, promoting neuronal survival and plasticity GDNF-like Activity: Glial cell line-derived neurotrophic factor-like effects support dopaminergic neuron survival CNTF-like Activity: Ciliary neurotrophic factor-like components support oligodendrocyte and motor neuron function Anti-apoptotic Effects: Reduces caspase-mediated neuronal apoptosis in ischemic and neurodegenerative models Amyloid Modulation: Some evidence suggests effects on amyloid precursor protein processing relevant to Alzheimer's disease research Fundamental Contrast: Dihexa represents a reductionist approach one molecule, one target (HGF/c-Met), exceptional potency
For those not yet ready for standard titration, microdosing tirzepatide offers an alternative approach that starts even lower than 2.5 mg
